Form 4: Teladoc Health CEO Jason Gorevic Reports Stock Transactions
SEC Filing
Teladoc Health's CEO, Jason Gorevic, reports the acquisition and disposal of common stock and derivative securities, including performance stock units and restricted stock units.
Summary
- Jason Gorevic, CEO of Teladoc Health, filed a Form 4 detailing changes in beneficial ownership.
- On March 1, 2024, Gorevic acquired shares through the conversion of performance stock units and restricted stock units.
- He acquired 21,130 shares, 2,915 shares, 5,782 shares, 5,615 shares, 62,004 shares and 7,648 shares through conversion of derivative securities.
- On March 4, 2024, he disposed of 53,755 shares of common stock at a price of $14.516 per share.
- Following these transactions, Gorevic beneficially owns 653,073 shares of Teladoc Health common stock directly.
- He also holds 63,393 Performance Stock Units, 42,263 Performance Stock Units, 22,460 Restricted Stock Units and 124,008 Restricted Stock Units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, which carries a neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in the healthcare technology industry.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, depending on the overall market reaction.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of earliest transaction: Acquisition of shares through conversion of performance stock units and restricted stock units. |
| 03/04/2024 | Sale of 53,755 shares of common stock at $14.516 per share. |
| 03/05/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.